224 followers
RT @FrontImmunol: New Research: Use of gliptins reduces levels of SDF-1/CXCL12 in bullous pemphigoid and type 2 diabetes, but does not incr…
RT @FrontImmunol: New Research: Use of gliptins reduces levels of SDF-1/CXCL12 in bullous pemphigoid and type 2 diabetes, but does not incr…
New Research: Use of gliptins reduces levels of SDF-1/CXCL12 in bullous pemphigoid and type 2 diabetes, but does not increase autoantibodies against BP180 in diabetic patients: The use of dipeptidyl peptidase 4 (DPP4) inhibitors, (also known… https://t.co/